First batch of Sputnik V, Russia's Covid19 vaccine to reach India

 The first batch of Sputnik V, Russia's Covid 19 vaccine is likely to reach India this week. As per PTI, the vaccine is all set to reach Kanpur's Ganesh Shankar Vidyarthi Medical College this week. Supportive arrangement are made to store the vaccine doses appropriately since it needs to be stored under a temperature range of -20 degree Celsius to -70 degree Celsius.

Once the vaccine reaches Kanpur, the Phase 2 and 3 human clinical trials are expected to start, for which close to 180 volunteers have registered already. As a start, one dosage of the vaccine will be administered to the volunteers and their conditions will be monitored. The expected duration for monitoring may go up-to somewhere 6-7 months to be able to give a concrete confirmation on the vaccine effectiveness. Dosage are expected to be administered once, twice or thrice with appropriate interval of 21 days during the monitoring period.


The human trials are being started after Dr. Reddy's Laboratories got Drug Controller General of India (DGCI) approval for the same recently. Dr. Reddy Laboratories and Russian Direct Investment Fund (RDIF), which is the Russia's sovereign wealth fund, had entered into a partnership to conduct clinical trials of Sputnik V and its subsequent distribution in the country wherein 100 million vaccine doses shall be supplied to India based on regulatory approvals.

Sputnik V became the world's first registered vaccine for Covid-19 on August 11th, 2020. Recently early this month , they also announced the trial results to be 92% effective. This announcement came 2 days after Pfizer announced 90% clinical trial effectiveness of their vaccine.

No comments

If you liked this blog then Join me at:
Facebook
Twitter
RSS

You might like